Drug Topics November 9, 2024
Brian Nowosielski

Stephen Schondelmeyer, PharmD, PhD, FAPhA, gave a presentation on US drug shortages and their global implications.

In order to ensure the safety and integrity of the US drug supply chain, it’s important for all parties acting within it to consider the drugs themselves as critical infrastructure to the country as a whole, not just within the pharmaceutical industry. With so much of the active pharmaceutical ingredients (APIs) of drugs being imported from other countries like India and China, drug shortages have become an increasingly significant issue that threatens the fabric of critical infrastructure within the US.

“The first point I want to make is drugs are critical infrastructure, and drug shortages have created a real challenge for us. When you...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Bariatric Surgeons Being Put Out of Work by GLP-1 Drugs
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025
Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
Why Walgreens Is Reportedly Considering a Private Equity Buyer

Share This Article